Cefowell-TZ 562.5

Description

Effective Infection Control with Cefowell-TZ 562.5 Injection

Cefowell-TZ 562.5 is a specialized injectable formulation that combines a third-generation cephalosporin with a potent beta-lactamase inhibitor. This synergy ensures that the antibiotic remains effective even against resistant bacterial strains, making it a reliable choice for critical care and complex infections.

Composition:

• Ceftriaxone Sodium (500mg): A broad-spectrum antibiotic that inhibits bacterial cell wall synthesis, effectively killing a wide variety of bacteria.

• Tazobactam Sodium (62.5mg): A beta-lactamase inhibitor that protects Ceftriaxone from degradation by resistant bacteria, expanding its therapeutic reach.

Key Benefits:

• Overcomes Resistance: Effectively treats infections caused by beta-lactamase-producing organisms that are resistant to standard antibiotics.

• Broad-Spectrum Coverage: Works against both Gram-positive and Gram-negative aerobic and anaerobic bacteria.

• Fast Acting: Being an injectable, it enters the bloodstream directly for rapid therapeutic action in acute conditions.

• Versatile Treatment: Proven efficacy in treating respiratory, urinary, and surgical site infections.

Clinical Indications:

• Lower Respiratory Tract Infections (Pneumonia and Bronchitis).

• Urinary Tract Infections (UTI).

• Surgical Prophylaxis (to prevent post-operative infections).

• Bacterial Septicemia and Meningitis.

• Bone, Joint, and Intra-abdominal infections.

Administration & Dosage:

• Route: For Intramuscular (IM) or Intravenous (IV) use.

• Dosage: As prescribed by a qualified physician based on the severity of the infection and patient weight.

• Storage: Store in a cool, dry place protected from light. Use the solution immediately after reconstitution.